Nuvation Bio Inc. (NUVB)

Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	28.16	28.53	31.92	24.28	10.95	6.99
Research & Development	65.34	71.29	87.82	65.25	32.6	25.11
Operating Expenses	93.5	99.82	119.73	89.53	43.55	32.1
Operating Income	-93.5	-99.82	-119.73	-89.53	-43.55	-32.1
Interest Expense	-	-	-	-	-	-2.66
Interest & Investment Income	26.76	24.61	7.45	2.96	1.95	1.29
Other Non Operating Income (Expenses)	-2.09	-0.45	9.32	3.59	-0.27	-0.14
EBT Excluding Unusual Items	-68.83	-75.66	-102.97	-82.98	-41.88	-33.61
Gain (Loss) on Sale of Investments	-0.04	-0.14	-1.23	-0.08	0.22	0.05
Pretax Income	-68.87	-75.8	-104.2	-86.85	-41.66	-33.55
Net Income	-68.87	-75.8	-104.2	-86.85	-41.66	-33.55
Net Income to Common	-68.87	-75.8	-104.2	-86.85	-41.66	-33.55
Shares Outstanding (Basic)	219	219	217	198	98	207
Shares Outstanding (Diluted)	219	219	217	198	98	207
Shares Change (YoY)	0.41%	1.00%	9.52%	102.90%	-52.81%	155.19%
EPS (Basic)	-0.31	-0.35	-0.48	-0.44	-0.43	-0.16
EPS (Diluted)	-0.31	-0.35	-0.48	-0.44	-0.43	-0.16
Free Cash Flow	-64.46	-68.07	-96.48	-68.47	-36.67	-25.09
Free Cash Flow Per Share	-0.29	-0.31	-0.45	-0.35	-0.38	-0.12
EBITDA	-93.28	-99.6	-119.54	-89.35	-43.45	-32.09
D&A For EBITDA	0.22	0.22	0.2	0.18	0.1	0.01
EBIT	-93.5	-99.82	-119.73	-89.53	-43.55	-32.1

Source: S&P Capital IQ. Standard template.